ArticleBMC medicine2024

Long-term comparison of renal and metabolic outcomes after sodium-glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes.

Minji Sohn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.